Quote this publication Share Print

MENVEO

-
Opinions on drugs - Posted on Apr 03 2014

Reason for request

Extension of indication

-


Actual benefit

Important

Substantial


Improvement in actual benefit

V (absence)

MENVEO does not provide any improvement in actual benefit (IAB V, non-existent) in the prevention of invasive meningococcal infections caused by serogroups A, C, W135, Y in children from 2 to 10 years of age.